Thursday, April 01, 2004
Experimental Drug Slows Type 1 Diabetes
Here's some promising news from the first human trials of Diamyd. This drug which slows the autoimmune response may be a neat complement to the Edmonton protocol.
to read the full WebMD article.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)